What is the role of tiotropium in asthma?: A systematic review with meta-analysis

Chest

Volumn 147, Issue 2, 2015, Pages 388-396

  Rodrigo, Gustavo J ^a   Castro Rodríguez, José A ^b  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; SALBUTAMOL; SCOPOLAMINE DERIVATIVE;

ADD ON THERAPY; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE 7; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; META ANALYSIS; MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE; MONOTHERAPY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; ANALOGS AND DERIVATIVES; DISEASE COURSE; DRUG COMBINATION; INTENTION TO TREAT ANALYSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ALBUTEROL; ASTHMA; CHOLINERGIC ANTAGONISTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HUMANS; INTENTION TO TREAT ANALYSIS; QUALITY OF LIFE; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

EID: 84928084942     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1698     Document Type: Article

References (35)

1. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med. 2000; 161 ( 6): 1862-1868.
2. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Th orax. 2005; 60 ( 9): 740-746.
3. Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev. 2004;( 3): CD003269.
4. Fardon T, Haggart K, Lee DKC, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fl uticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med. 2007; 101 ( 6): 1218-1228.
5. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med. 2008; 102 ( 1): 50-56.
6. Peters SP, Kunselman SJ, Icitovic N, et al; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010; 363 ( 18): 1715-1726.
7. Befekadu E, Onofrei C, Colice GL. Tiotropium in asthma: a systematic review. J Asthma Allergy. 2014; 7: 11-21.
8. Tian JW, Chen JW, Chen R, Chen X. Tiotropium versus placebo for inadequately controlled asthma: a meta-analysis. Respir Care. 2014; 59 ( 5): 654-666.
9. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009; 151 ( 4): W-65-W-94.
10. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Ques tionnaire. Eur Respir J. 1999; 14 ( 1): 32-38.
11. Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005; 99 ( 5): 553-558.
12. Safety Guidelines. International Conference on Harmonisa tion of Technical Requirements for Reg istration of Pharmaceuticals for Human Use website. http://www. ich. org/products/guidelines/ safety/article/safety-guidelines. html. Accessed May 10, 2014.
13. Higgins JPT, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928.
14. Higgins JPT, Th ompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. B MJ. 2003; 327 ( 7414): 557-560.
15. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. Chichester, West Sussex, England: John Wiley and Sons; 2009.
16. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity, combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. London, England: BMJ Publishing Group; 2001:285-312.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315 ( 7109): 629-634.
18. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol. 2011; 128 ( 2): 315-322.
19. Kerstjens HAM, Disse B, Schröder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol. 2011; 128 ( 2): 308-314.
20. Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012; 367 ( 13): 1198-1207.
21. Clinical trials. BI Trial No.: 205. 464. Boehringer Ingelheim website. http://trials. boehringer-ingelheim. com/content/ dam/internet/opu/clinicaltrial/com-EN/ results/205/205. 464-U13-2279-01. pdf. Accessed on May 10, 2014.
22. Clinical trials. BI Trial No.: 205. 420. Boehringer Ingelheim website. http:// trials. boehringer-ingelheim. com/ content/dam/internet/opu/clinicaltrial/ com-EN/results/205/205. 420-U12-2227-01-DS. pdf. Accessed on May 10, 2014.
23. Vogelberg C, Engel M, Moroni-Zentgraf P, et al. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: A randomised dose-ranging study. Respir Med. 2014; 108 ( 9): 1268-1276.
24. Beeh KM, Moroni-Zentgraf P, Ablinger O, et al. Tiotropium Respimat in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma. Respir Res. 2014; 15: 61.
25. Clinical trials. BI Trial No.: 205. 442. Boehringer Ingelheim website. http:// trials. boehringer-ingelheim. com/ content/dam/internet/opu/clinicaltrial/ com-EN/results/205/205. 442-U13-1003-01. pdf. Accessed on May 10, 2014.
26. Clinical trials. BI Trial No.: 205. 418. Boehringer Ingelheim website. http:// trials. boehringer-ingelheim. com/content/ dam/internet/opu/clinicaltrial/com-EN/ results/205/205. 418-c02036039-03. pdf. Accessed on May 10, 2014.
27. Clinical trials. BI Trial No.: 205. 419. Boehringer Ingelheim website. http:// trials. boehringer-ingelheim. com/content/ dam/internet/opu/clinicaltrial/com-EN/ results/205/205. 419-c02036086-05. pdf. Accessed on May 10, 2014.
28. Clinical trials. BI Trial No.: 205. 444. Boehringer Ingelheim website. http:// trials. boehringer-ingelheim. com/content/ dam/internet/opu/clinicaltrial/com-EN/ results/205/205. 444-c01846621-02. pdf. Accessed on September 8, 2014.
29. GINA report, global strategy for the asthma management and prevention. Global Initiative for Asthma website. http://www. ginasthma. org/local/uploads/ fi les/GINA-Report-2014-Jun11. pdf. Accessed July 10, 2014.
30. Reddel HK, Taylor DR, Bateman ED, et al; American Th oracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An offi cial American Th oracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180 ( 1): 59-99.
31. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005; 2 ( 1): 111-124.
32. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important diff erences in pharmacological trials. Am J Respir Crit Care Med. 2014; 189 ( 3): 250-255.
33. Bel EH. Tiotropium for asthma-promise and caution. N Engl J Med. 2012; 367 ( 13): 1257-1259.
34. Loke YK, Singh S, Furberg CD. Tiotropium and the risk of death in COPD. N Engl J Med. 2014; 370 ( 5): 480-481.
35. Verhamme KMC, van Blijderveen N, Sturkenboom MCJM. Tiotropium and the risk of death in COPD. N Engl J Med. 2014; 370 ( 5): 481-482.